Search Results - "JANSEN, E. N. H"

Refine Results
  1. 1

    Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's disease by FARKAS, E, DE JONG, G. I, DE VOS, R. A. I, STEUR, E. N. H. J, LUITEN, P. G. M

    Published in Acta neuropathologica (01-10-2000)
    “…Cerebral capillaries represent a major interface between the general circulation and the central nervous system and are responsible for sufficient and…”
    Get full text
    Journal Article
  2. 2

    Cognitive status correlates with neuropathologic stage in Parkinson disease by BRAAK, H, RÜB, U, STEUR, E. N. H. Jansen, DEL TREDICI, K, DE VOS, R. A. I

    Published in Neurology (26-04-2005)
    “…To study the association of cognitive status with the stages of a published neuropathologic staging procedure for sporadic Parkinson disease (PD) in a cohort…”
    Get full text
    Journal Article
  3. 3

    Parkinson's disease : affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system by BRAAK, H, RÜB, U, SANDMANN-KEIL, D, WEI PING GAI, DE VOS, R. A. I, STEUR, E. N. H. J, ARAI, K, BRAAK, E

    Published in Acta neuropathologica (01-05-2000)
    “…Pathological changes which consistently develop in the lower brain stem of patients suffering from Parkinson's disease are described against the background of…”
    Get full text
    Journal Article
  4. 4

    Activated microglial cells and complement factors are unrelated to cortical Lewy bodies by ROZEMULLER, A. J. M, EIKELENBOOM, P, THEEUWES, J. W, STEUR, E. N. H. Jansen, DE VOS, R. A. I

    Published in Acta neuropathologica (01-12-2000)
    “…Inflammatory mechanisms have been demonstrated in Alzheimer's disease (AD) but their presence in other neurodegenerative disorders is not well documented…”
    Get full text
    Journal Article
  5. 5

    Progressive supranuclear palsy: neuronal and glial cytoskeletal pathology in the higher order processing autonomic nuclei of the lower brainstem by Rüb, U., Del Tredici, K., Schultz, C., De Vos, R. A. I., Jansen Steur, E. N. H., Arai, K., Braak, H.

    Published in Neuropathology and applied neurobiology (01-02-2002)
    “…The medial and lateral parabrachial nuclei (MPB, LPB), the gigantocellular reticular nucleus (GI), the raphes magnus (RMG) and raphes obscurus nuclei (ROB), as…”
    Get full text
    Journal Article
  6. 6

    Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigra by van Muiswinkel, F.L, de Vos, R.A.I, Bol, J.G.J.M, Andringa, G, Jansen Steur, E.N.H, Ross, D, Siegel, D, Drukarch, B

    Published in Neurobiology of aging (01-10-2004)
    “…Dopamine (DA) autooxidation, and consequent formation of neurotoxic DA-derived quinones and reactive oxygen species, has been implicated in dopaminergic cell…”
    Get full text
    Journal Article
  7. 7

    Pattern of brain destruction in Parkinson's and Alzheimer's diseases by Braak, H, Braak, E, Yilmazer, D, de Vos, R A, Jansen, E N, Bohl, J

    Published in Journal of Neural Transmission (01-01-1996)
    “…Alzheimer's disease (AD) and Parkinson's disease (PD) are the most common age-related degenerative disorders of the human brain. Both diseases involve multiple…”
    Get full text
    Journal Article
  8. 8

    Clozapine in the treatment of tremor in Parkinson's disease by Jansen, E N

    Published in Acta neurologica Scandinavica (01-04-1994)
    “…Tremor at rest is a classic symptom of Parkinson's disease that causes significant disability and distress for the patient and is generally only weakly…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Pharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease: a study of five different suppositories by van Laar, T, Jansen, E N, Neef, C, Danhof, M, Roos, R A

    Published in Movement disorders (01-07-1995)
    “…The pharmacokinetics and clinical effects of apomorphine after rectal administration were determined in five patients with idiopathic Parkinson's disease (PD)…”
    Get more information
    Journal Article
  11. 11

    Primary cerebellar nocardiosis and alveolar proteinosis by Oerlemans, W. G. H., Jansen, E. N. H., Prevo, R. L., Eijsvogel, M. M. M.

    Published in Acta neurologica Scandinavica (01-02-1998)
    “…We report a patient with known asymptomatic pulmonary alveolar proteinosis (PAP) who developed a cerebellar gait disorder and dysarthria caused by an isolated…”
    Get full text
    Journal Article
  12. 12

    Tuberculous meningitis: pitfalls in diagnosis by Joosten, A. A. J., Van Der Valk, P. D. L. P. M., Geelen, J. A. G., Severin, W. P. J., Jansen Steur, E. N. H.

    Published in Acta neurologica Scandinavica (01-12-2000)
    “…Objectives– The diagnosis of tuberculous meningitis is easily missed because the variety of symptoms give rise to problems with the differential diagnosis…”
    Get full text
    Journal Article
  13. 13

    Pharmacokinetics of apomorphine in Parkinson's disease: plasma and cerebrospinal fluid levels in relation to motor responses by Hofstee, D J, Neef, C, van Laar, T, Jansen, E N

    Published in Clinical neuropharmacology (01-02-1994)
    “…In this study, we measured the relationship between plasma and cerebrospinal fluid (CSF) apomorphine levels and their clinical effects in two patients with…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease by WOLTERS, E. C, JANSEN, E. N. H, TUYNMAN-QUA, H. G, BERGMANS, P. L. M

    Published in Neurology (01-10-1996)
    “…We studied the effect of olanzapine (1 to 15 mg/d) in 15 nondemented parkinsonian patients with drug-induced psychosis. Psychotic symptoms decreased…”
    Get full text
    Journal Article
  16. 16

    Amygdala pathology in Parkinson's disease by BRAAK, H, BRAAK, E, YILMAZER, D, DE VOS, R. A. I, JANSEN, E. N. H, BOHL, J, JELLINGER, K

    Published in Acta neuropathologica (01-12-1994)
    “…The amygdala undergoes severe pathological changes during the course of Parkinson's disease (PD). Lewy bodies and Lewy neurites are distributed in a specific…”
    Get full text
    Journal Article
  17. 17

    Cerebrovascular hypoperfusion: a risk factor for Alzheimer's disease? Animal model and postmortem human studies by De Jong, G I, De Vos, R A, Steur, E N, Luiten, P G

    Published in Annals of the New York Academy of Sciences (26-09-1997)
    “…Although cognitive impairment during aging is usually associated with neuronal alterations, the cerebrovascular system undergoes prominent alterations in aging…”
    Get full text
    Journal Article
  18. 18

    Intranasal apomorphine in parkinsonian on-off fluctuations by van Laar, T, Jansen, E N, Essink, A W, Neef, C

    Published in Archives of neurology (Chicago) (01-05-1992)
    “…The efficacy of intranasal apomorphine was assessed in seven patients with Parkinson's disease and severe levodopa (L-dopa)-related "off-period" disabilities…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Increase of Parkinson disability after fluoxetine medication by JANSEN STEUR, E. N. H

    Published in Neurology (1993)
    “…Depression is a major clinical feature of Parkinson's disease. We report the increased amount of motor disability in four patients with idiopathic Parkinson's…”
    Get full text
    Journal Article